Traditional Chinese medicine composition for regulating cerebral-intestinal axis

A traditional Chinese medicine composition consisting of herbs such as hibiscus regulates the brain-gut axis, solving the treatment challenges of multi-system diseases, improving gut microbiota, and alleviating mental illnesses, demonstrating significant therapeutic effects.

CN118903318AActive Publication Date: 2024-11-08SHANDONG UNIV OF TRADITIONAL CHINESE MEDICINE +3
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202411030740.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-30
Publication Date
2024-11-08
Estimated Expiration
2044-07-30

AI Technical Summary

Technical Problem

Existing technologies lack traditional Chinese medicine compositions developed based on the 'brain-gut axis' mechanism, which cannot effectively regulate multi-system diseases involving the digestive, nervous, and endocrine systems.

Method used

This traditional Chinese medicine composition, consisting of six herbs—hibiscus, bitter orange, perilla, ophiopogon japonicus, polygonatum odoratum, tangerine peel, anemarrhena asphodeloides, poria cocos, and licorice—is used in various dosage forms, such as decoctions, granules, and pills, to regulate the brain-gut axis and achieve the goal of treating multi-system diseases.

Benefits of technology

It significantly improves the metabolic function of gut microbiota, restores gut balance, improves sleep quality, and alleviates mental illnesses such as anxiety and depression, demonstrating significant therapeutic effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004969863220000061
    Figure BDA0004969863220000061
  • Figure BDA0004969863220000071
    Figure BDA0004969863220000071
  • Figure BDA0004969863220000091
    Figure BDA0004969863220000091
Patent Text Reader

Abstract

The invention discloses a traditional Chinese medicine composition for regulating cerebral-intestinal axis. The traditional Chinese medicine composition is characterized by being prepared from the following raw medicinal materials in parts by weight: 10-20 parts of roselle, 8-16 parts of seville orange flower, 6-12 parts of purple perilla, 4-8 parts of radix ophiopogonis, 2-4 parts of radix polygonati officinalis, 2-4 parts of pericarpium citri reticulatae, 2-4 parts of rhizoma anemarrhenae, 2-4 parts of poria cocos and 2-4 parts of liquorice. According to a brain-intestinal axis mechanism, the purpose of safely and effectively treating diseases of multiple systems such as a digestive system, a nervous system and an endocrine system is achieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a Chinese medicine composition, in particular to a Chinese medicine composition for regulating the brain-gut axis. Background Art

[0002] The "brain-gut axis" is a bidirectional pathway between the central nervous system and the digestive system that is connected through a neuro-endocrine-immune network. Brain-gut peptides are key effector molecules that exist both in the central nervous system and in the gastrointestinal tract to act as hormones. Brain-gut peptides can play a wide range of regulatory roles in the gastrointestinal tract and brain in an autocrine, paracrine, and neurotransmitter manner. This process is a process of mutual intervention and mutual regulation between the body's central nervous system and gastrointestinal function, also known as the "brain-gut interaction" process.

[0003] The "brain-gut axis" involves a variety of factors in the human body, such as microorganisms, metabolites, and neuroactive peptides, and transmits information through neural pathways such as the sympathetic nervous system and the vagus nerve. Based on this, modern research believes that the important pathogenesis of digestive system diseases is the disorder of "brain-gut interaction", especially digestive system diseases accompanied by mental abnormalities. Changes in thinking and emotions will lead to changes in visceral functions such as gastrointestinal sensation, gastrointestinal smooth muscle motility, and gastrointestinal mucosal gland secretion. At the same time, gastrointestinal activity can also react to the central nervous system, affecting the emotions, spirit, and even behavior it regulates.

[0004] In summary, abnormal distribution of brain gut peptides is closely related to the disorder of neuro-endocrine-immune regulation and the imbalance of "brain-gut interaction". The "brain-gut axis" links the gastrointestinal tract and the central nervous system, making the two physiologically and pathologically connected. They can influence and regulate each other through the "brain-gut interaction" process, which reasonably explains the mechanism of mutual dependence and restraint in the occurrence and development of gastrointestinal diseases and nervous system diseases.

[0005] For example, in the neuro-endocrine pathway, the intestinal flora stimulates the afferent neurons of the enteric nervous system to create synaptic connections between the enteric nerves and the vagus nerves, forming information conduction, thereby achieving information exchange between the intestinal flora and the brain. Studies have shown that the imbalance of intestinal flora may be an important cause of insomnia. When the balance of intestinal flora is broken, the metabolic function and metabolite levels of the intestinal flora will decrease, the body's "brain-gut axis" will be activated, and the sleep duration will be shorter than fragmented sleep, affecting the quality of sleep.

[0006] At present, there are many Chinese medicines for treating specific diseases of the digestive system, nervous system, endocrine system, etc., but no Chinese medicine has been found to treat body diseases based on the mechanism of "brain-gut axis". Therefore, combining the pathological mechanism of Western medicine with the treatment method of traditional Chinese medicine, developing a Chinese medicine composition for comprehensive regulation of multiple systems such as the digestive system, nervous system, endocrine system, etc., has important social significance and economic value. Summary of the invention

[0007] The technical problem to be solved by the present invention is to provide a Chinese medicine composition for regulating the brain-gut axis, based on the mechanism of the "brain-gut axis", to achieve the purpose of safely and effectively treating multiple system diseases such as the digestive system, nervous system, and endocrine system.

[0008] In order to solve this technical problem, the present invention adopts the following technical solutions:

[0009] A Chinese medicine composition for regulating the brain-gut axis is prepared from the following raw medicinal materials: roselle, daisy flower, perilla, ophiopogon, polygonatum, tangerine peel, anemarrhena, tuckahoe and liquorice.

[0010] Preferably, the Chinese medicine composition for regulating the brain-gut axis is composed of the following medicinal materials in parts by weight: 10-20 parts of Roselle, 8-16 parts of Daisy Flower, 6-12 parts of Perilla, 4-8 parts of Ophiopogon, 2-4 parts of Polygonatum, 2-4 parts of Tangerine Peel, 2-4 parts of Anemarrhena, 2-4 parts of Poria, and 2-4 parts of Licorice.

[0011] Further preferably, the traditional Chinese medicine composition for regulating the brain-gut axis is composed of the following medicinal materials in parts by weight: 15 parts of Roselle, 10 parts of Daisy Flower, 9 parts of Perilla, 6 parts of Ophiopogon, 3 parts of Polygonatum, 3 parts of Citrus Reticulata, 3 parts of Anemarrhena Asphodeloides, 3 parts of Poria, and 3 parts of Licorice.

[0012] The dosage form of the Chinese medicine composition for regulating the brain-gut axis is a decoction, and its preparation comprises the following steps:

[0013] (1) After the drugs are weighed, mixed together and put into a container;

[0014] (2) adding water to a container, boiling it over high heat, then simmering it over low heat to obtain a filtrate;

[0015] (3) Repeat step (2) and mix the two filtrates to obtain a decoction of the Chinese medicine composition.

[0016] A medicine for regulating the brain-gut axis is prepared from the traditional Chinese medicine composition or from the traditional Chinese medicine composition and pharmaceutically acceptable excipients.

[0017] Preferably, the dosage form of the drug for regulating the brain-gut axis is a decoction, and its preparation comprises the following steps:

[0018] (1) After the drugs are weighed, mixed together and put into a container;

[0019] (2) adding water to a container, boiling it over high heat, then simmering it over low heat to obtain a filtrate;

[0020] (3) Repeat step (2), mix the two filtrates, add decoction excipients, and obtain a decoction of the medicine.

[0021] Preferably, the drug for regulating the brain-gut axis is in the form of an granule, and its preparation comprises the following steps:

[0022] (1) After the drugs are weighed, mixed together and put into a container;

[0023] (2) adding water to a container, boiling it over high heat, then simmering it over low heat to obtain a filtrate;

[0024] (3) repeating step (2) and mixing the two filtrates to obtain a Chinese medicine solution;

[0025] (4) The Chinese medicine liquid is boiled over a low fire to be concentrated into a medicinal paste, which is then dried, crushed, and added to the auxiliary materials for the granules to obtain the medicinal granules.

[0026] Preferably, the dosage form of the drug for regulating the brain-gut axis is a water pill, and its preparation comprises the following steps:

[0027] (1) weigh and mix Perilla frutescens, Radix Ophiopogonis, Pericarpium Citri Reticulatae and Radix Glycyrrhizae, and put them into a container;

[0028] (2) adding water to a container, boiling it over high heat, then simmering it over low heat to obtain a filtrate;

[0029] (3) repeating step (2) and mixing the two filtrates to obtain a Chinese medicine solution;

[0030] (4) After weighing and mixing Roselle, Daidaihua, Anemarrhena, Polygonatum, and Poria, the mixture is ground into fine Chinese medicine powder as the base material for water pills;

[0031] (5) mixing the fine Chinese medicine powder obtained in step (4) with the Chinese medicine liquid obtained in step (3), adding water pill excipients, and making pills;

[0032] (6) After the pills are dried, water-based pills of the drug are obtained.

[0033] The solution of this prescription is as follows:

[0034] Roselle is the main ingredient in the prescription. It is cool in nature and sour in taste. It enters the stomach, liver, and kidney meridians. It has the effects of strengthening the stomach and digestion, promoting fluid production and quenching thirst, clearing away heat and removing fire, and promoting blood circulation and replenishing blood.

[0035] The daidaihua in the prescription is sweet, slightly bitter, and flat, and has the effects of regulating qi and widening the chest, stimulating appetite and stopping vomiting; the perilla is pungent and warm, and enters the lung and spleen meridians, and has the effects of dispelling cold, promoting qi, and harmonizing the stomach. These two flavors assist the main medicine and the monarch medicine, and are together the auxiliary medicine and the minister medicine.

[0036] The Ophiopogon japonicus in the prescription is sweet, slightly bitter, and slightly cold, and it enters the heart, lung, and stomach meridians, and has the effects of nourishing yin, promoting fluid production, moistening the lungs, and clearing the heart; Polygonatum odoratum is sweet, slightly cold, and enters the lung and stomach meridians, and has a sweet and liquid taste, soft and moisturizing, nourishing without being greasy, and has no disadvantages of lingering evil, and is especially good at nourishing the yin fluid of the lungs and stomach; Tangerine peel is bitter and pungent, warm, and enters the lung and spleen meridians, and has the effects of regulating qi, strengthening the spleen, and removing dampness and phlegm; Anemarrhena asphodeloides is bitter, sweet, and cold, and enters the lung, stomach, and kidney meridians, and has the effects of promoting fluid production, moistening dryness, and clearing heat and purging fire; Poria cocos is flat, sweet, and light, and enters the heart, spleen, lung, and kidneys, and has the effects of promoting water, penetrating dampness, and strengthening the spleen and calming the heart. The above five herbs help the power of the monarch and ministers, and are collectively adjuvants.

[0037] The licorice in the formula is sweet and mild in taste, and enters the heart, lung, spleen, and stomach meridians. It has the effect of harmonizing various medicines and serves as a guiding drug.

[0038] The combination of the above medicines is consistent with the prescription and the symptoms, and the medicine and the symptoms correspond to each other, and the therapeutic effect is direct and significant.

[0039] The positive effects of the present invention are:

[0040] The present invention is based on TCM syndrome differentiation and treatment, has the effects of nourishing the spleen and stomach, regulating qi and relieving pain, and has a significant therapeutic effect on gastrointestinal diseases (symptoms such as bloating, pain, noise, heartburn, hiccups, nausea and vomiting); the present invention can also regulate the intestinal flora, improve the metabolic function of the intestinal flora and the level of metabolites, and restore the balance of the intestine.

[0041] In addition, based on the "brain-gut axis" mechanism, the present invention can also activate the body's "brain-gut interaction" process. In the process of treating gastrointestinal diseases, it can also effectively improve sleep quality and relieve mental illnesses such as anxiety and depression. DETAILED DESCRIPTION

[0042] In order to better understand and implement the present invention, the present invention is further described below in conjunction with specific embodiments.

[0043] Experimental Example 1: Exploring the effects of Chinese medicine prescriptions on sleep and intestinal flora in mice

[0044] The mice were randomly divided into a Chinese medicine group, a diazepam group and a control group, and were gavaged for 7 consecutive days. The Chinese medicine group was given a Chinese medicine formula (20 g / kg animal body weight) every day, the diazepam group was given diazepam (3 mg / kg animal body weight) every day, and the control group was given the same volume of pure water as the Chinese medicine group every day.

[0045] The Chinese medicine group is administered with a decoction of the Chinese medicine prescription of the present invention daily, and its preparation comprises the following steps:

[0046] (1) Take 15 parts of Roselle, 10 parts of Daidaihua, 9 parts of Perilla, 6 parts of Radix Ophiopogonis, 3 parts of Polygonatum, 3 parts of Tangerine Peel, 3 parts of Rhizoma Anemarrhenae, 3 parts of Poria, and 3 parts of Radix Glycyrrhizae, weigh them well, mix them together, and put them into a container for boiling Chinese medicine;

[0047] (2) Add 500 ml of water to a container, soak for about half an hour, boil over high heat, then simmer for another half an hour over low heat to obtain a filtrate;

[0048] (3) Repeat step (2) and mix the two filtrates (about 300 ml) to obtain a decoction of the Chinese medicine composition.

[0049] The specific tests are as follows:

[0050] (1) Subthreshold dose hypnosis test of sodium pentobarbital:

[0051] Before the formal experiment, a preliminary experiment was conducted to determine the maximum subthreshold dose of sodium pentobarbital at which the righting reflex of 80-90% of mice did not disappear, i.e., the subthreshold hypnotic dose of sodium pentobarbital (generally 16-30 mg / kg animal body weight, determined to be 24 mg / kg animal body weight in the preliminary experiment).

[0052] The animals were administered once a day. 30 minutes after administration (the Chinese medicine formula of the present invention or diazepam or purified water), each group of animals was intraperitoneally injected with the maximum subthreshold hypnotic dose of sodium pentobarbital at 24 mg / kg animal body weight. The number of animals that fell asleep within 30 minutes (those with loss of righting reflex for more than 1 minute) was recorded. The results are shown in Table 1.

[0053] Table 1 Sample sodium pentobarbital subthreshold dose hypnosis test

[0054] Group Total number of animals Number of sleeping animals Sleep incidence (%) Control group 12 0 0 Chinese Medicine Group 12 4 33.3%* Diazepam group 12 8 67%**

[0055] *, ** indicate that the other groups were compared with the control group, P<0.05, P<0.01.

[0056] As shown in Table 1, compared with the control group, the incidence of sleep in the mice in the Chinese medicine group was significantly increased (P<0.05). The incidence of sleep in the diazepam group was significantly increased compared with the control group (P<0.01), and the incidence of sleep in the diazepam group was higher than that in the Chinese medicine group.

[0057] (2) Sodium barbital sleep latency test:

[0058] Before the formal experiment, a preliminary experiment was conducted to determine the dose of sodium barbital (generally 200-300 mg / kg animal body weight) that would make the animals fall asleep 100% but not sleep too long. The dose was determined to be 260 mg / kg animal body weight in the preliminary experiment, and this dose was used in the formal experiment.

[0059] The animals were administered once a day. 30 minutes after administration (the Chinese medicine formula of the present invention or diazepam or purified water), 260 mg / kg animal body weight of barbital sodium was intraperitoneally injected into the animals of each group. The injection volume was 0.2 mL / 20 g animal body weight. The disappearance of righting reflex was used as an indicator to observe the effect of the test sample on the sleep latency of barbital sodium. The results are shown in Table 2.

[0060] Table 2 Sample sodium barbital sleep latency test (Mean ± SEM)

[0061] Group Sleep latency (min) Control group 57.4±4.2 Chinese Medicine Group 48.1±3.1* Diazepam group 33.9±3.3**

[0062] , *, * indicates that other groups were compared with the control group, P<0.05, P<0.01.

[0063] As shown in Table 2, compared with the control group, the sleep latency of mice in the Chinese medicine group was significantly shortened (P<0.05). The sleep latency of mice in the diazepam group was significantly shortened (P<0.01), and the sleep latency of mice in the diazepam group was shorter than that in the Chinese medicine group.

[0064] The results of test (1) and test (2) showed that after the samples were continuously gavaged into the mice for 7 days, the results of both the "pentobarbital sodium subthreshold dose hypnosis test" and the "pentobarbital sodium sleep latency test" were positive. This shows that although the Chinese medicine formula of the present invention cannot treat insomnia symptoms like the positive drug diazepam, it can also significantly improve the sleep quality of mice.

[0065] (3) Intestinal microbial testing:

[0066] After the end of experiment (2), the feces of the mice in the control group and the Chinese medicine group were collected and placed in a conical bottle containing sterile water and glass beads. After shaking at 120r / min for 30min, the plate was spread and cultured and counted. The number of bifidobacteria, lactobacilli, bacteroides and enterococci was detected. The mixed bacteria method was used for counting, and each dilution was repeated 3 times to calculate the number of each bacteria contained in each gram of intestinal content. The results are shown in Table 3.

[0067] Table 3 Effects of Chinese medicine prescriptions on intestinal microorganisms in sleep improvement test animals (viable bacteria count / ×10 7 cfu·g -1 )

[0068] Group Number of animals Bifidobacterium count Lactobacillus Bacteroides Enterococci Control group 12 4.6±0.8 7.9±1.6 5.2±0.9 6.6±1.1 Chinese Medicine Group 12 <![CDATA[8.2±1.0 ## ]]> <![CDATA[9.7±1.1 # ]]> 5.0±0.8 5.9±1.0

[0069] # , ## It means that the difference between the Chinese medicine group and the control group was P<0.05, P<0.01.

[0070] As shown in Table 3, compared with the control group, the number of bifidobacteria and lactobacilli in the intestinal flora of mice in the Chinese medicine group increased significantly (P<0.05; P<0.01), indicating that the Chinese medicine formula of the present invention has a significant improvement effect on the intestinal flora of mice.

[0071] Experimental Example 2: Investigating the effect of Chinese medicine formula on animal feces status and flora

[0072] (1) Animal loose stool frequency and loose stool rate test:

[0073] Animal grouping and modeling: After 3 days of adaptive feeding, the mice were randomly divided into a normal group and a model group. The mice in the model group were gavaged with mixed antibiotics (gentamicin sulfate + cefradine capsules) to establish a dysbacteriosis diarrhea model. The criteria for successful modeling were: lack of luster in hair, reduced food intake, curled up mice, less activity, slower reaction, slower movements, and obvious stains on the anus. After successful modeling, the mice in the model group were randomly divided into a model control group and a Chinese medicine treatment group, with 10 animals in each group. The Chinese medicine treatment group was given a Chinese medicine prescription of 20g / kg animal body weight, and the normal group and the model control group were given the same volume of pure water as the Chinese medicine treatment group.

[0074] The Chinese medicine group is administered with a decoction of the Chinese medicine prescription of the present invention daily, and its preparation comprises the following steps:

[0075] (1) Take 15 parts of Roselle, 10 parts of Daidaihua, 9 parts of Perilla, 6 parts of Radix Ophiopogonis, 3 parts of Polygonatum, 3 parts of Tangerine Peel, 3 parts of Rhizoma Anemarrhenae, 3 parts of Poria, and 3 parts of Radix Glycyrrhizae, weigh them well, mix them together, and put them into a container for boiling Chinese medicine;

[0076] (2) Add 500 ml of water to a container, soak for about half an hour, boil over high heat, then simmer for another half an hour over low heat to obtain a filtrate;

[0077] (3) Repeat step (2) and mix the two filtrates (about 300 ml) to obtain a decoction of the Chinese medicine composition.

[0078] The number of loose stools for each mouse was recorded, and the loose stool rate (ratio of loose stools to the total number of stools) was calculated. The results are shown in Table 4.

[0079] Table 4 Effects of Chinese medicine formula on the frequency and rate of loose stools in diarrheal animals

[0080]

[0081]

[0082] ** indicates that the model control group was compared with the normal group, P<0.01. # Indicates that the TCM treatment group was compared with the model control group, P<0.05.

[0083] As shown in Table 4, compared with the normal group, the loose stool frequency and loose stool rate of mice in the model control group were significantly increased (P < 0.01), indicating that the constipation animal model was successfully established. Compared with the model control group, the loose stool rate of animals in the Chinese medicine treatment group was significantly reduced (P < 0.05), but there was no statistical difference in the loose stool frequency of animals (P > 0.05). The above research results show that the Chinese medicine prescription of the present invention has a significant improvement on the symptoms of diarrhea animals.

[0084] (2) Intestinal microbial testing:

[0085] After the experiment (1) was completed, the feces of the mice were collected and placed in a conical bottle containing sterile water and glass beads. After shaking at 120 r / min for 30 min, the feces were spread on a plate and cultured and counted. The number of bifidobacteria, lactobacilli, bacteroides and enterococci was detected. The mixed bacteria method was used for counting, and each dilution was repeated 3 times to calculate the number of each bacteria contained in each gram of intestinal content. The results are shown in Table 5.

[0086] Table 5 Effects of Chinese medicine formula on intestinal microorganisms in animals (viable bacteria count / ×107 cfu·g-1)

[0087] Group Number of animals Bifidobacterium count Lactobacillus Bacteroides Enterococci Normal group 10 4.1±0.9 6.2±1.1 4.0±1.1 5.1±1.0 Model control group 10 2.8±0.9** 3.8±1.2** 5.3±1.4* 6.8±1.1** Chinese medicine treatment group 10 <![CDATA[3.8±0.9 # ]]> <![CDATA[5.7±0.9 ## ]]> 5.0±1.2 <![CDATA[5.7±1.0 # ]]>

[0088] *, * indicates that the model control group was compared with the normal group, P<0.05, P<0.01. # , ## It indicates that the difference between the Chinese medicine treatment group and the model control group was P<0.05, P<0.01.

[0089] As shown in Table 5, compared with the normal group, the number of bifidobacteria and lactobacilli in the intestinal flora of mice in the model control group was significantly reduced (P < 0.01), and the number of Bacteroides and Enterococci was significantly increased compared with the normal group (P < 0.05; P < 0.01). Compared with the model control group, the number of bifidobacteria and lactobacilli in the intestinal flora of mice in the Chinese medicine treatment group was significantly increased (P < 0.05; P < 0.01), and the number of Enterococci was significantly reduced (P < 0.05), but there was no significant effect on Bacteroides. The above research results show that the Chinese medicine prescription of the present invention has a significant improvement effect on intestinal flora.

[0090] Experimental Example 3: Exploring the clinical efficacy of traditional Chinese medicine formula in treating constipation in the elderly

[0091] Method: A total of 58 elderly patients with constipation were included, 30 in the treatment group and 28 in the control group. The control group did not take any medicine, while the treatment group was treated with the Chinese medicine prescription of the present invention. The treatment group was given the decoction, granules or water pills of the Chinese medicine prescription of the present invention every day.

[0092] The preparation of the decoction comprises the following steps:

[0093] (1) Take 15 parts of Roselle, 10 parts of Daidaihua, 9 parts of Perilla, 6 parts of Radix Ophiopogonis, 3 parts of Polygonatum, 3 parts of Tangerine Peel, 3 parts of Rhizoma Anemarrhenae, 3 parts of Poria, and 3 parts of Radix Glycyrrhizae, weigh them well, mix them together, and put them into a container for boiling Chinese medicine;

[0094] (2) Add 500 ml of water to a container, soak for about half an hour, boil over high heat, then simmer for another half an hour over low heat to obtain a filtrate;

[0095] (3) Repeat step (2), mix the two filtrates (about 300 ml), add decoction excipients, and obtain a decoction of the medicine.

[0096] The dosage of the decoction is: the above preparation amount is for one day, the patient takes 1 / 3 of the dosage (i.e. about 100 ml) each time, divided into 3 doses a day, each time about half an hour after a meal.

[0097] The preparation of the granules comprises the following steps:

[0098] (1) Take 15 parts of Roselle, 10 parts of Daidaihua, 9 parts of Perilla, 6 parts of Radix Ophiopogonis, 3 parts of Polygonatum, 3 parts of Tangerine Peel, 3 parts of Rhizoma Anemarrhenae, 3 parts of Poria, and 3 parts of Radix Glycyrrhizae, weigh them well, mix them together, and put them into a container for boiling Chinese medicine;

[0099] (2) Add 500 ml of water to a container, soak for about half an hour, boil over high heat, then simmer for another half an hour over low heat to obtain a filtrate;

[0100] (3) Repeat step (2) and mix the two filtrates (about 300 ml) to obtain a Chinese medicine solution;

[0101] (4) The Chinese medicine liquid is boiled over a low fire to be concentrated into a medicinal paste, which is then placed in a drying oven and dried at 60 degrees. After drying, it is crushed and an appropriate amount of auxiliary materials for granules is added (the amount of auxiliary materials is based on the amount of 18 g when mixed with the pulverized medicinal powder) to obtain a medicinal granule.

[0102] The dosage of the granules is: the above preparation amount is for one day, the patient takes 6 grams at a time, 3 times a day, about half an hour after each meal.

[0103] The preparation of water pills includes the following steps:

[0104] (1) 9 parts of Perilla frutescens, 6 parts of Radix Ophiopogonis, 3 parts of Perilla frutescens, and 3 parts of Radix Glycyrrhizae are weighed and mixed together, and then put into a container for boiling Chinese medicine;

[0105] (2) Add 500 ml of water to a container, soak for about half an hour, boil over high heat, then simmer for another half an hour over low heat to obtain a filtrate;

[0106] (3) Repeat step (2) and mix the two filtrates (about 300 ml) to obtain a Chinese medicine solution, which is then boiled over low heat and concentrated to about 30 ml.

[0107] (4) Mix and grind 15 parts of Roselle, 10 parts of Daidaihua, 3 parts of Anemarrhena, 3 parts of Polygonatum, and 3 parts of Poria into fine powder as the base of water pills;

[0108] (5) mixing the fine Chinese medicine powder obtained in step (4) with the Chinese medicine liquid obtained in step (3), adding water pill excipients, and making pills;

[0109] (6) After drying the pills (so that each water pill weighs about 18 g), the water pills of the drug are obtained.

[0110] The dosage of the water pill is: the above preparation amount is for one day, the patient takes 6 grams at a time, 3 times a day, about half an hour after each meal.

[0111] The scales were evaluated once before and after treatment (including weekly bowel movements (SBM), Cleveland constipation rating scale (CCS), self-rating constipation symptom scale (PAC-SYM), self-rating anxiety scale (SAS) and self-rating depression scale (SDS)), and the clinical efficacy was compared between the two groups.

[0112] (1) Assessment of constipation: The test results are shown in Tables 6 and 7.

[0113] Table 6 SBM frequency table

[0114] Group n Before treatment After treatment Control group 28 2(2,3) 6(5,7) Treatment Group 30 2(2,3) <![CDATA[4(3,5) # ]]>

[0115] # It means that P<0.05 was compared between the treatment group and the control group after treatment.

[0116] As shown in Table 6, the weekly bowel movement frequency in the treatment group after treatment was significantly higher than that in the control group (P<0.05).

[0117] Table 7 Comparison of Cleveland Constipation Scale (CCS) scores and PAC-SYM scores

[0118]

[0119] # It means that P<0.05 was compared between the treatment group and the control group after treatment.

[0120] As shown in Table 7, the CCS scores and PAC-SYM scores of the treatment group after treatment were significantly lower than those of the control group (P<0.05).

[0121] (2) Psychological status assessment: The test results are shown in Table 8.

[0122] Table 8 Comparison of Self-Rating Anxiety Scale (SAS) and Self-Rating Depression Scale (SDS)

[0123]

[0124] # It means that P<0.05 was compared between the treatment group and the control group after treatment.

[0125] As shown in Table 8, the SAS and SDS scores of the treatment group after treatment were significantly lower than those of the control group, and the difference was statistically significant (P<0.05).

[0126] The above results indicate that the Chinese medicine formula of the present invention has a significant improvement effect on the gastrointestinal system and nervous system of the human body.

Claims

1. A Chinese medicine composition for regulating the brain-gut axis, characterized in that The medicine is prepared from the following raw medicinal materials: roselle, daidaihua, perilla, ophiopogon, polygonatum, tangerine peel, anemarrhena, tuckahoe and liquorice.

2. The Chinese medicine composition for regulating the brain-gut axis according to claim 1, characterized in that The medicine is composed of the following medicinal materials in parts by weight: 10-20 parts of roselle, 8-16 parts of daisy flower, 6-12 parts of perilla, 4-8 parts of ophiopogon, 2-4 parts of polygonatum, 2-4 parts of tangerine peel, 2-4 parts of anemarrhena, 2-4 parts of poria and 2-4 parts of liquorice.

3. The Chinese medicine composition for regulating the brain-gut axis according to claim 2, characterized in that The drug is composed of the following medicinal materials in parts by weight: 15 parts of roselle, 10 parts of daisy flower, 9 parts of perilla, 6 parts of ophiopogon, 3 parts of polygonatum, 3 parts of tangerine peel, 3 parts of anemarrhena, 3 parts of poria, and 3 parts of liquorice.

4. The Chinese medicine composition for regulating the brain-gut axis according to any one of claims 1 to 3, characterized in that The dosage form of the Chinese medicine composition is a decoction, and its preparation comprises the following steps: (1) After the drugs are weighed, mix them together and put them into a container; (2) Add water to a container, boil it over high heat, then simmer over low heat to obtain a filtrate; (3) Repeat step (2) and mix the two filtrates to obtain a decoction of the Chinese medicine composition.

5. A drug for regulating the brain-gut axis, made from the Chinese medicine composition of any one of claims 1 to 3 or made from the Chinese medicine composition of any one of claims 1 to 3 and pharmaceutically acceptable excipients.

6. The drug for regulating the brain-gut axis according to claim 5, characterized in that The dosage form of the drug is a decoction, and its preparation includes the following steps: (1) After the drugs are weighed, mix them together and put them into a container; (2) Add water to a container, boil it over high heat, then simmer over low heat to obtain a filtrate; (3) Repeat step (2), mix the two filtrates, add decoction excipients, and obtain a decoction of the medicine.

7. The drug for regulating the brain-gut axis according to claim 5, characterized in that The dosage form of the drug is a granule, and its preparation comprises the following steps: (1) After the drugs are weighed, mix them together and put them into a container; (2) Add water to a container, boil it over high heat, then simmer over low heat to obtain a filtrate; (3) Repeat step (2) and mix the two filtrates to obtain a Chinese medicine solution; (4) The Chinese medicine liquid is boiled over low heat to concentrate into a medicinal paste, which is then dried, crushed, and added to the auxiliary materials for the granule to obtain the medicinal granule.

8. The drug for regulating the brain-gut axis according to claim 5, characterized in that The dosage form of the drug is a water pill, and its preparation comprises the following steps: (1) Weigh the perilla, ophiopogon japonicus, dried orange peel and liquorice, mix them together and put them into a container; (2) Add water to a container, boil it over high heat, then simmer over low heat to obtain a filtrate; (3) Repeat step (2) and mix the two filtrates to obtain a Chinese medicine solution; (4) Weigh the mixture of Roselle, Daidaihua, Anemarrhena, Polygonatum, and Poria, mix and grind into fine Chinese medicine powder as the base of water pills; (5) mixing the fine Chinese medicine powder obtained in step (4) with the Chinese medicine liquid obtained in step (3), adding water pill excipients, and making pills; (6) After the pills are dried, the water-based pills are obtained.

Citation Information

Patent Citations

  • Traditional Chinese medicine formulation for treating qi depression type insomnia

    CN105288255A

  • Medicinal and edible dampness clearing formula

    CN113197999A

  • Formula and preparation process of additive-free plum syrup

    CN114097963A

  • Plant-based composition based on intestine-brain axis and preparation method thereof

    CN116114875A

  • Traditional Chinese medicine composition for improving gastrointestinal function and regulating intestinal flora

    CN117414395A